Permanent neonatal diabetes mellitus: Prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study

Pediatric Diabetes

Volumn 14, Issue 3, 2013, Pages 174-180

  Kanakatti Shankar, Roopa ^a   Pihoker, Catherine ^b   Dolan, Lawrence M ^a   Standiford, Debra ^a   Badaru, Angela ^b   Dabelea, Dana ^c   Rodriguez, Beatriz ^d   Black, Mary Helen ^e   Imperatore, Giuseppina ^f   Hattersley, Andrew ^g   Ellard, Sian ^g   Gilliam, Lisa K ^h  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Global Health and Health Disparities   (United States)

^d KUAKINI MEDICAL CENTER   (United States)

^e Kaiser Permanente Southern California ^*  (United States)

^f NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^g UNIVERSITY OF EXETER   (United Kingdom)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ABCC8; Infant; INS; KCNJ11; Neonatal diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL;

ARTICLE; GENE; GENE MUTATION; GENETIC SCREENING; HEALTH CARE PERSONNEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GENE; KCNJ11 GENE; NEWBORN; NEWBORN DIABETES MELLITUS; PERMANENT NEWBORN DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INSULIN; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PREVALENCE; SULFONYLUREA RECEPTORS; UNITED STATES; YOUNG ADULT;

EID: 84876795114     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12003     Document Type: Article

References (27)

1. Aguilar-Bryan L, Bryan J. Neonatal diabetes mellitus. Endocr Rev 2008: 29: 265-291.
2. Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis 2007: 2: 12.
3. Iafusco D, Massa O, Pasquino B et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90, 000 live births. Acta Diabetol 2011 [Epub ahead of print].
4. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6months of life, with the phenotype determined by genotype. Diabetologia 2006: 49: 1190-1197.
5. Edghill EL, Dix RJ, Flanagan SE et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6months. Diabetes 2006: 55: 1895-1898.
6. Iafusco D, Stazi MA, Cotichini R et al. Permanent diabetes mellitus in the first year of life. Diabetologia 2002: 45: 798-804.
7. Slingerland AS, Hattersley AT. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Ann Med 2005: 37: 186-195.
8. Gloyn AL, Pearson ER, Antcliff JF et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004: 350: 1838-1849.
9. Babenko AP, Polak M, Cave H et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006: 355: 456-466.
10. Edghill EL, Flanagan SE, Patch AM et al. Insulin mutation screening in 1, 044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008: 57: 1034-1042.
11. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008: 4: 200-213.
12. Gloyn AL. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 2003: 22: 353-362.
13. Pearson ER, Flechtner I, Njolstad PR et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006: 355: 467-477.
14. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008: 31: 204-209.
15. Gloyn AL, Diatloff-Zito C, Edghill EL et al. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 2006: 14: 824-830.
16. Koster JC, Cadario F, Peruzzi C, Colombo C, Nichols CG, Barbetti F. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J Clin Endocrinol Metab 2008: 93: 1054-1061.
17. Slingerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene. Diabetologia 2006: 49: 2559-2563.
18. SEARCH Study Group. SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004: 25: 458-471.
19. Liese AD, D'Agostino RB Jr, Hamman RF et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006: 118: 1510-1518.
20. Dabelea D, Bell RA, D'Agostino RB Jr et al. Incidence of diabetes in youth in the United States. JAMA 2007: 297: 2716-2724.
21. Bonifacio E, Yu L, Williams AK et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab 2010: 95: 3360-3367.
22. Flanagan SE, Clauin S, Bellanne-Chantelot C et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009: 30: 170-180.
23. Sheehy MJ, Scharf SJ, Rowe JR et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989: 83: 830-835.
24. Slingerland AS, Shields BM, Flanagan SE et al. Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260, 000 live births. Diabetologia 2009: 52: 1683-1685.
25. Stanik J, Gasperikova D, Paskova M et al. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 2007: 92: 1276-1282.
26. Russo L, Iafusco D, Brescianini S et al. Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia 2011: 54: 1693-1701.
27. Stoy J, Greeley SA, Paz VP et al. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008: 9: 450-459.